COVID-19: US FDA, CDC support Pfizer-BioNTech boosters for people high-risk or aged 65+
CA, 24 Sep 2021
The U.S. Food and Drug Administration (FDA) and an advisory panel for the Centers for Disease Control and Prevention have largely approved the use of a third dose of the Pfizer-BioNTech COVID-19 vaccine.
Officials say Americans aged 65 years and older, and those 18 and up who have a high risk for severe disease should receive a booster shot.
Jackson Proskow reports on if Canada is looking to follow suit, and how scientists feel about the general public getting a third dose.
For more info, please go to https://globalnews.ca/news/8216138/covid-vaccine-booster-canada-fda/
Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB